Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II
| প্রধান লেখক: | , , |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | English |
| প্রকাশিত: |
Frontiers Media S.A.
2024-02-01
|
| মালা: | Frontiers in Medicine |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1371720/full |
| _version_ | 1827365272992874496 |
|---|---|
| author | Ana Sandoval-Rodriguez Aldo Torre-Delgadillo Juan Armendariz-Borunda Juan Armendariz-Borunda |
| author_facet | Ana Sandoval-Rodriguez Aldo Torre-Delgadillo Juan Armendariz-Borunda Juan Armendariz-Borunda |
| author_sort | Ana Sandoval-Rodriguez |
| collection | DOAJ |
| first_indexed | 2024-03-08T08:24:51Z |
| format | Article |
| id | doaj.art-da3ce7b4d2fe41feb00055b6c7060624 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-03-08T08:24:51Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-da3ce7b4d2fe41feb00055b6c70606242024-02-02T04:52:30ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-02-011110.3389/fmed.2024.13717201371720Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume IIAna Sandoval-Rodriguez0Aldo Torre-Delgadillo1Juan Armendariz-Borunda2Juan Armendariz-Borunda3Institute of Molecular Biology in Medicine and Gene Therapy, Centro Universitario de Ciencias de la Salud, University of Guadalajara, Guadalajara, Jalisco, MexicoHepatology and Liver Transplantation Unit, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), Mexico City, MexicoInstitute of Molecular Biology in Medicine and Gene Therapy, Centro Universitario de Ciencias de la Salud, University of Guadalajara, Guadalajara, Jalisco, MexicoTecnologico de Monterrey, School of Medicine and Health Sciences, Guadalajara, Mexicohttps://www.frontiersin.org/articles/10.3389/fmed.2024.1371720/fullliver fibrosisMAFLDMASLDsteatotic liver diseasenon-alcoholic steatohepatitis (NASH) |
| spellingShingle | Ana Sandoval-Rodriguez Aldo Torre-Delgadillo Juan Armendariz-Borunda Juan Armendariz-Borunda Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II Frontiers in Medicine liver fibrosis MAFLD MASLD steatotic liver disease non-alcoholic steatohepatitis (NASH) |
| title | Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II |
| title_full | Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II |
| title_fullStr | Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II |
| title_full_unstemmed | Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II |
| title_short | Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II |
| title_sort | editorial community series liver fibrosis and mafld from molecular aspects to novel pharmacological strategies volume ii |
| topic | liver fibrosis MAFLD MASLD steatotic liver disease non-alcoholic steatohepatitis (NASH) |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2024.1371720/full |
| work_keys_str_mv | AT anasandovalrodriguez editorialcommunityseriesliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategiesvolumeii AT aldotorredelgadillo editorialcommunityseriesliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategiesvolumeii AT juanarmendarizborunda editorialcommunityseriesliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategiesvolumeii AT juanarmendarizborunda editorialcommunityseriesliverfibrosisandmafldfrommolecularaspectstonovelpharmacologicalstrategiesvolumeii |